Skip to main content

Table 1 Clinical and biological features of HTLV-1-infected patients with RA

From: Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease

Patient

Sex

Age

Associated Diseases

Disease duration (year)

Sharp score

ESR (mm)

CRP (mg/l)

RF (IU/ml)

Treatment

HTLV-1 proviral load (copies / 106 PBMCs)

1

F

75

-

7

65

111

313

128

Corticosteroids, DMARDs

373,300

2

F

63

HAM/TSP

2

10

70

5

32

Corticosteroids, DMARDs

39,800

3

F

62

-

9

3

41

6

-

NSAIDs

126,500

4

F

58

-

7

46

5

3

64

Corticosteroids, DMARDs

55,000

5

F

72

-

7

109

56

16

-

NSAIDs, DMARDs

38,500

6

F

59

-

10

5

38

5

-

Corticosteroids, DMARDs

28,900

7

F

64

-

2

8

25

12

128

Corticosteroids, DMARDs

79,800

8

F

69

-

16

126

21

30

16

Corticosteroids, DMARDs

230,000

9

F

57

HAM/TSP

13

6

29

13

-

Corticosteroids

247,400

10

F

58

HAM/TSP

2

17

35

9

32

Corticosteroids, DMARDs

106,500

11

F

42

-

18

3

22

5

-

Analgesics

32,200

12

F

77

HAM/TSP

7

110

88

41

-

Corticosteroids, DMARDs

14,600

  1. Sharp score : joint space narrowing score and erosion score; CRP: C-reactive protein; ESR, erythrocyte sedimentation rate; RF: rheumatoid factor; NSAIDs: non-steroidal anti-inflammatory drugs; DMARDs: disease-modifying anti-rheumatic drugs (hydroxychloroquine, leflunomide, methotrexate, etc.)